The VITAL project focused on immunosenescence, vaccination response, disease burden modelling, and cost-benefit analyses for aging populations.
UNIVERSITE JEAN MONNET
French university contributing health epidemiology, radiation testing for electronics, and SME innovation support across diverse EU consortia.
Their core work
Université Jean Monnet is a French public university based in Saint-Étienne with diverse research capabilities spanning infectious disease epidemiology, radiation effects on electronics, and innovation support for SMEs. In H2020, they contributed expertise in vaccination strategies for aging populations, participated in radiation testing infrastructure for industry applications, and supported photonics-based digital innovation hubs. Their involvement reflects a broad university mandate rather than a single specialized niche, with contributions tailored to each consortium's needs.
What they specialise in
RADNEXT provided access to radiation testing facilities for automotive, avionics, and space electronics applications.
PhotonHub Europe delivered deep innovation support, investment coaching, and training for SMEs through EU digital innovation hubs.
How they've shifted over time
Université Jean Monnet's H2020 involvement began in 2019 with health-focused research on vaccination and infectious disease in aging populations, emphasizing epidemiological modelling and public health communication. By 2021, their activity shifted toward technology infrastructure and business innovation — radiation testing for industrial electronics and SME support through digital innovation hubs. This trajectory suggests the university is broadening from pure health research toward applied technology services and industry-facing innovation support.
Moving from health research toward applied technology services and industry engagement, suggesting growing interest in technology transfer and business-facing roles.
How they like to work
Université Jean Monnet operates exclusively as a supporting partner or third-party contributor — they have never coordinated an H2020 project. Their participation in large consortia (132 unique partners across 23 countries) indicates they join broad, multi-partner networks rather than leading small focused teams. This profile suggests a university that contributes specialized expertise to established projects rather than driving research agendas independently.
Through just 3 projects, they are embedded in consortia spanning 132 unique partners across 23 countries, reflecting the large scale of the projects they join rather than an extensive self-built network. Their reach is pan-European with no obvious geographic concentration beyond France.
What sets them apart
What makes Université Jean Monnet unusual is the breadth of their H2020 involvement — spanning health epidemiology, radiation physics, and SME business innovation within just three projects. For consortium builders, this signals a versatile university partner comfortable contributing across very different domains. Based in Saint-Étienne (a mid-sized French industrial city), they may offer regional industry connections that larger metropolitan universities lack.
Highlights from their portfolio
- VITALTheir largest funded project (EUR 200,000), addressing the timely topic of vaccination strategies for aging populations with disease burden modelling and cost-benefit analysis.
- RADNEXTProvides access to radiation testing infrastructure serving automotive, avionics, and space industries — a rare capability bridging fundamental physics and industrial reliability testing.